Free Trial
NASDAQ:ACCD

Accolade 1/10/2025 Earnings Report

Accolade EPS Results

Actual EPS
-$0.30
Consensus EPS
-$0.31
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Accolade Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Accolade Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Accolade Earnings Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
See More Accolade Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Accolade? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accolade and other key companies, straight to your email.

About Accolade

Accolade (NASDAQ:ACCD) (NASDAQ: ACCD) is a healthcare technology company that offers personalized health and benefits solutions designed to improve consumer experience and optimize healthcare outcomes. The company’s cloud-based platform combines advanced data analytics, digital tools, and dedicated healthcare professionals to guide individuals through complex healthcare and benefits decisions. Accolade’s core services include personalized health assistance, virtual care coordination, benefits navigation, and condition management, all delivered through a single integrated digital experience.

Founded in 2007 and headquartered in Seattle, Washington, Accolade has expanded its presence across the United States and into international markets, including the United Kingdom. The company partners primarily with large employers, health plans, and brokerages to deliver its services to millions of members and employees. By leveraging proprietary technology and a network of nurse advocates, health assistants and specialists, Accolade aims to reduce the friction often associated with accessing care and to drive better clinical and financial outcomes for its clients.

Throughout its history, Accolade has focused on innovation in consumer engagement and care navigation. Its digital platform integrates with electronic health records (EHRs), pharmacy benefit management systems, and other healthcare data sources to provide real-time insights and personalized recommendations. These integrations enable Accolade’s care teams to proactively identify high-risk individuals, streamline care pathways, and facilitate seamless communication between patients, providers, and payers.

Leadership at Accolade includes co-founder and Chief Executive Officer Rajeev Singh, who has guided the company’s growth and product development since its inception. Under his direction, Accolade has assembled an experienced management team with deep expertise in healthcare, technology, and benefits administration. As the healthcare landscape continues to evolve, Accolade remains focused on delivering consumer-centric solutions that enhance access to care, improve member satisfaction, and drive value for its clients.

View Accolade Profile

More Earnings Resources from MarketBeat